Articles

It becomes tough to take the body of the deceased from one place to the other since there are plenty of logistical details involved while arranging the corpse transportation. But when you choose Panchmukhi Dead Body Transportation Service in Delhi, you have the advantage of taking the dead body to the specific location without any difficulties, as we have facilities that are especially designed to keep dead bodies intact all along the way. We are dedicated to offering compassionate and professional corpse transportation services that involve the best facilities, intending to support the needs of the common people and ensuring the entire process is effective in all possible aspects. We understand how much of an intricate and sorrowful process it is to lose your loved one and want to ease your burden by giving you a reliable solution for the transportation of your departed loved one via our Body Freezer Mortuary Box Transportation in Delhi. The Intricate Task of Taking the Dead Body to ... Continue reading →

According to FutureWise analysis the market for monoclonal antibody therapy in 2026 is US$ 359.42 billion, and is expected to reach US$ 1028.77 billion by 2036 at a CAGR of 11.09%. The growth in monoclonal antibodies is attributed to their expanding use in oncology, autoimmune disorders, infectious diseases, and rare genetic conditions. Advances in antibody engineering, biosimilars, and targeted immunotherapies are improving treatment efficacy and accessibility. Additionally, rising R&D investments and regulatory approvals for next-generation biologics are set to drive market expansion. Monoclonal antibody therapy represents a significant advancement in targeted treatment, playing a transformative role in fields such as oncology, immunology, and the management of infectious diseases. These monoclonal antibodies (mAbs) are specifically engineered proteins that simulate the immune system’s natural ability to combat harmful pathogens, including viruses, and to identify and ... Continue reading →

According to FutureWise analysis the market for Motion Sickness Treatment in 2026 is US$ 0.88 billion, and is expected to reach US$ 1.27 billion by 2036 at a CAGR of 3.74%. Market growth is driven by increasing global travel, cruise tourism, and the use of VR technologies that cause motion-related discomfort. Innovations in non-drowsy formulations, transdermal patches, and combination therapies are improving patient convenience. Additionally, rising awareness of over-the-counter treatments is boosting demand in both developed and emerging markets. Motion sickness is a common condition that arises mainly during travel, where the brain struggles to harmonize the sensory information it receives from the eyes, ears, and nose. Symptoms can range from clumsiness and nausea to, in some instances, a high fever. Factors that may increase susceptibility to motion sickness include frequent travel, the use of hormonal birth control, a family history of the condition, migraines, and certain ... Continue reading →

According to FutureWise analysis the market for motion stimulation therapy in 2026 is US$ 1.35 billion, and is expected to reach US$ 2.14 billion by 2036 at a CAGR of 4.71%. The market is growing due to rising demand for non-invasive rehabilitation in neurology, orthopedics, and sports medicine. Advances in wearable stimulation devices and digital health integration are improving therapy precision and outcomes. Additionally, increasing mobility disorders and a focus on early physical rehabilitation are driving sustained market expansion. Motion stimulation therapy is an advanced therapeutic method that utilizes controlled mechanical, electrical, or sensory stimuli to enhance movement, improve neuromuscular function, and aid in physical rehabilitation. This therapy is strategically designed to engage muscles, nerves, and sensory pathways, playing a significant role in restoring mobility and functional independence for patients with neurological disorders, musculoskeletal injuries, and ... Continue reading →

According to FutureWise analysis, the Mortuary Equipment market in 2026 is US$1.12 billion, and is expected to reach US$1.93 billion by 2036 at a CAGR of 5.59%.  The mortuary equipment market is experiencing significant growth, primarily due to the increasing global mortality rate driven by aging populations and the rising prevalence of chronic diseases worldwide. The expansion of healthcare infrastructure, particularly in emerging economies, is resulting in higher investments in modern mortuary facilities equipped with advanced refrigeration systems, autopsy tables, and embalming stations. Technological advancements in mortuary equipment, such as automated body storage systems and energy-efficient refrigeration units, are enhancing operational efficiency and reducing costs for healthcare facilities. Additionally, an increasing number of forensic investigations and the need for proper body preservation in legal and medical contexts are further driving market demand. ... Continue reading →

According to FutureWise analysis the market for Motorized Prosthesis in 2026 is US$ 92.15 million, and is expected to reach US$ 183.42 million by 2036 at a CAGR of 7.13%. Market growth is fueled by advancements in robotics, sensor technologies, and myoelectric control systems that improve mobility and functionality. The rising incidence of limb loss from diabetes, trauma, and vascular diseases boosts demand for advanced prosthetics. Additionally, increased research investments and better reimbursement frameworks are promoting the global adoption of motorized prosthetic devices. Motorized prostheses are advanced artificial limb systems that utilize electric motors and sophisticated sensor technologies to restore functional movement for individuals who have lost limbs. Unlike traditional passive prosthetics, these motorized devices actively assist with motion, enabling users to perform complex tasks with enhanced precision, strength, and coordination. This innovation marks a significant ... Continue reading →

According to FutureWise analysis, the Mosquito-borne infections testing market in 2026 is US$26.47 billion, and is expected to reach US$45.33 billion by 2036 at a CAGR of 5.53%.  The market for testing mosquito-borne infections is experiencing significant growth due to the rising global incidence of diseases such as dengue, malaria, Zika virus, chikungunya, and West Nile virus, particularly in tropical and subtropical regions. Climate change is expanding the habitats and transmission zones for mosquitoes, leading to outbreaks in previously unaffected areas and increasing the demand for widespread diagnostic testing. Advancements in rapid diagnostic tests, molecular diagnostics, and point-of-care testing technologies are improving detection accuracy and accessibility, especially in resource-limited settings. Additionally, government initiatives and funding from international health organizations aimed at surveillance and control programs for mosquito-borne diseases are ... Continue reading →

According to FutureWise analysis, the motion preservation devices market in 2026 is US$2.06 billion, and is expected to reach US$4.83 billion by 2036 at a CAGR of 8.90%.  The motion preservation devices market is experiencing substantial growth, primarily due to a growing preference for motion-preserving spinal surgeries over traditional spinal fusion techniques. These devices maintain natural biomechanics and help reduce adjacent segment degeneration, which is a significant concern in traditional surgeries. The demand for motion preservation devices is further driven by the rising prevalence of degenerative disc diseases, spinal stenosis, and other spinal disorders, particularly within aging populations. Technological advancements, such as artificial disc replacements, dynamic stabilization systems, and interspinous spacers, are contributing to improved clinical outcomes and expanding treatment options for patients who wish to preserve spinal mobility. Increased awareness among ... Continue reading →

According to FutureWise analysis the market for Mouth Ulcer Treatment Drug in 2026 is US$ 1.94 billion, and is expected to reach US$ 2.71 billion by 2036 at a CAGR of 3.40%. Market growth is fueled by the high prevalence of recurrent aphthous stomatitis, rising stress levels, and increased awareness of oral healthcare. The availability of over-the-counter treatments like topical gels and mouthwashes supports steady demand. Research into faster-acting and longer-lasting therapies is expected to improve treatment outcomes and patient comfort. Mouth ulcer treatment drugs are specifically formulated medications aimed at alleviating pain, reducing inflammation, and promoting faster healing of oral ulcers, which are commonly referred to as aphthous ulcers or canker sores. These painful lesions typically form on the inner cheeks, lips, tongue, gums, or the roof of the mouth. While most mouth ulcers are harmless and tend to resolve on their own, recurrent or severe cases can adversely affect ... Continue reading →

According to FutureWise analysis the market for moyamoya disease in 2026 is US$ 1.63 billion, and is expected to reach US$ 3.10 billion by 2036 at a CAGR of 6.64%. Market growth is driven by increasing awareness, improved diagnostic capabilities like MRI and cerebral angiography, and a rising prevalence in specific regions. Enhanced access to specialized neurosurgical interventions and ongoing research into new therapeutic approaches will also contribute to future development in this segment. Moyamoya Disease is a chronic cerebrovascular disorder characterized by the narrowing of specific blood vessels in the brain, particularly the internal carotid arteries. This narrowing, known as stenosis, leads to restricted blood flow due to thrombosis, or the formation of blood clots. In response to these blockages, the body attempts to develop collateral circulation; however, these newly formed vessels are often weak and prone to further complications, such as bleeding, aneurysm, or additional ... Continue reading →